Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
巴元明（通讯作者），An X, Peng B, Huang X, Jiang H, Xiong Z, Zhang H, Lian F, Ba Y, Tong X. Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial. Chin Med. 2022 Apr 2;17(1):42. doi: 10.1186/s13020-022-00602-x. PMID: 35366928; PMCID: PMC8976166.（IF:4.9）
